Outsourced Pharma Capacity Update Videos - Large Molecule

  1. Cytovance Biologics Capacity Update October 2024: Large Molecule Drug Substance 10/22/2024

    Senior Business Development Director Rose Rhomberg presents an in-depth look at Cytovance’s capabilities and highlights the available capacity designed to accelerate your goals.

  2. Novartis Contract Manufacturing Capacity Update October 2024: Large Molecule Drug Substance 10/22/2024

    Gain valuable insights into our mammalian development services, manufacturing solutions, upcoming capacity availability, as well as updates on expansion timelines for external clients.

  3. Pfizer CentreOne Capacity Update October 2024: Large Molecule Drug Substance 10/22/2024

    See how our specialized manufacturing site in Sanford, NC — backed by over 35 years of expertise in mAb production — can expedite the delivery of your groundbreaking therapies to patients.

  4. Resilience Capacity Update October 2024: Large Molecule Drug Substance 10/22/2024

    Business Head of Biologics and Vaccines Evan Pasenello shares how Resilience’s innovative platforms and specialized expertise can effectively support your development and manufacturing programs.

  5. Boehringer Ingelheim BioXcellence™ Capacity Update October 2024: Large Molecule Drug Substance 10/22/2024

    Explore our global production network, advanced aseptic filling, in-house analytics, and the expertise that has driven 47 biopharmaceuticals to market success.

  6. FUJIFILM Diosynth Biotechnologies Capacity Update October 2024: Large Molecule Drug Substance 10/22/2024

    Rasmus Pedersen, Ph.D., outlines strategies to expand large-molecule production capacity to meet the global medicine demand, noting the current gap that leaves 2 billion people without access.

  7. Samsung Biologics Capacity Update October 2024: Large Molecule Drug Substance 10/22/2024

    We're poised to be your next growth engine with our commitment to quality, speed, and agility, as we expand our facilities and invest in innovative modalities to meet your large molecule needs.

  8. Cytovance Capacity Update July 2024: Large Molecule Development 9/18/2024

    Centrally located in the United States, with a decades-long history in biologics development and manufacturing, Cytovance delivers ingenuity end-to-end to both large pharma and biotech clients alike.